TransMedics Group Inc (NAS:TMDX)
$ 83 -1.97 (-2.32%) Market Cap: 2.79 Bil Enterprise Value: 3.04 Bil PE Ratio: 88.30 PB Ratio: 13.26 GF Score: 76/100

Transmedics Group Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 12, 2022 / 03:40PM GMT
Release Date Price: $55.75 (+4.42%)
Unidentified Company Representative

Ready to go.

Cecilia E. Furlong
Morgan Stanley, Research Division - Equity Analyst

Yes. I think it's a morning. Good morning, almost afternoon, but good morning. I'm Cecilia Furlong, med tech analyst here at Morgan Stanley. It is my pleasure to have TransMedics with us, CEO, Waleed Hassanein, CFO, Stephen Gordon. Before we get started really quickly disclosures. For important disclosures, please see the disclosure website at morganstanley.com/researchdisclosures. With that, Stephen, Waleed, thank you both for being here.

Waleed H. Hassanein
TransMedics Group, Inc. - Founder, President, MD, CEO & Director

Thank you for your invitation.

Questions & Answers

Cecilia E. Furlong
Morgan Stanley, Research Division - Equity Analyst

So I wanted to start with current year outlook for the back half of this year. And during your 2Q call, you called out a lot of factors. You're balancing, though, have a macro that is more challenged while

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot